Asaleo Care sells Australian consumer tissue business to Solaris Paper for $180 million; extends license agreement with Essity

BOX HILL, Australia, Dec. 6, 2018 (Press Release) -Asaleo Care announces $180 million sale of Australian Consumer Tissue business and 5-year extension of License Agreement with Essity

  • $180 million sale of Australian Consumer Tissue business
  • In principle Agreement to 5-year extension of Trade Mark and Technology License Agreement with Essity to 2027
  • The Company will retain its Australasian Personal Care and B2B operations, as well as the Consumer Tissue business in New Zealand and Pacific Islands
  • Retained businesses have better margins, lower capital intensity, and strong cash flow
  • The sale is expected to improve EBITDA margin and be accretive to Group FY19 EBITDA forecast
  1. Sale of ...
Back To Top
Speak with a sales representative now Contact Sales